ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
274 hedge funds and large institutions have $4.55B invested in Intra-Cellular Therapies Inc. in 2023 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 110 increasing their positions, 86 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
3% less funds holding
Funds holding: 283 → 274 (-9)
16% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 44
Holders
274
Holding in Top 10
8
Calls
$54.4M
Puts
$14.4M
Top Buyers
| 1 | +$82.2M | |
| 2 | +$35.5M | |
| 3 | +$23.6M | |
| 4 |
ClearBridge Investments
New York
|
+$18.9M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$17.6M |
Top Sellers
| 1 | -$43.4M | |
| 2 | -$29.7M | |
| 3 | -$26.7M | |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$21.9M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$20.7M |